BioCentury
ARTICLE | Company News

Aarhus University Hospital, Exiqon deal

December 15, 2014 8:00 AM UTC

Exiqon received exclusive, worldwide rights to prostate cancer biomarkers comprising gene-specific methylation patterns for life science and diagnostic applications from the hospital. Exiqon plans to ...